Skip to main content
Clinical Trials/DRKS00021214
DRKS00021214
Completed
未知

Improvement of the nutritional status regarding nicotinamide (vitamin B3) and the course of COVID-19 disease - COVit

Klinik für Innere Medizin I (UKSH Campus Kiel)0 sites900 target enrollmentApril 1, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
U07.1
Sponsor
Klinik für Innere Medizin I (UKSH Campus Kiel)
Enrollment
900
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 1, 2020
End Date
October 20, 2022
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Klinik für Innere Medizin I (UKSH Campus Kiel)

Eligibility Criteria

Inclusion Criteria

  • SARS\-CoV\-2 infection confirmed by laboratory findings; the positive test must not date back more than 7 days.
  • Relevant infection symptoms, e.g. in the respiratory or gastrointestinal tract.
  • The patient has been able to give written consent via a website before any trial procedure is performed and can comply with the trial\-dependent prerequisites and requirements.

Exclusion Criteria

  • Current participation in another trial.
  • Pregnancy or breastfeeding.
  • Vaccination against SARS\-CoV\-2\.

Outcomes

Primary Outcomes

Not specified

Similar Trials